Literature DB >> 27270641

Cost-Effectiveness of Primary Care Management With or Without Early Physical Therapy for Acute Low Back Pain: Economic Evaluation of a Randomized Clinical Trial.

Julie M Fritz1, Minchul Kim2, John S Magel3, Carl V Asche2.   

Abstract

STUDY
DESIGN: Economic evaluation of a randomized clinical trial.
OBJECTIVE: Compare costs and cost-effectiveness of usual primary care management for patients with acute low back pain (LBP) with or without the addition of early physical therapy. SUMMARY OF BACKGROUND DATA: Low back pain is among the most common and costly conditions encountered in primary care. Early physical therapy after a new primary care consultation for acute LBP results in small clinical improvement but cost-effectiveness of a strategy of early physical therapy is unknown.
METHODS: Economic evaluation was conducted alongside a randomized clinical trial of patients with acute, nonspecific LBP consulting a primary care provider. All patients received usual primary care management and education, and were randomly assigned to receive four sessions of physical therapy or usual care of delaying referral consideration to permit spontaneous recovery. Data were collected in a randomized trial involving 220 participants age 18 to 60 with LBP <16 days duration without red flags or signs of nerve root compression. The EuroQoL EQ-5D health states were collected at baseline and after 1-year and used to compute the quality adjusted life year (QALY) gained. Direct (health care utilization) and indirect (work absence or reduced productivity) costs related to LBP were collected monthly and valued using standard costs. The incremental cost-effectiveness ratio was computed as incremental total costs divided by incremental QALYs.
RESULTS: Early physical therapy resulted in higher total 1-year costs (mean difference in adjusted total costs = $580, 95% CI: $175, $984, P = 0.005) and better quality of life (mean difference in QALYs = 0.02, 95% CI: 0.005, 0.35, P = 0.008) after 1-year. The incremental cost-effectiveness ratio was $32,058 (95% CI: $10,629, $151,161) per QALY.
CONCLUSION: Our results support early physical therapy as cost-effective relative to usual primary care after 1 year for patients with acute, nonspecific LBP. LEVEL OF EVIDENCE: 2.

Entities:  

Mesh:

Year:  2017        PMID: 27270641     DOI: 10.1097/BRS.0000000000001729

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  9 in total

1.  Evaluation of Cost-Utility of Thoracic Interlaminar Epidural Injections.

Authors:  Laxmaiah Manchikanti; Vidyasagar Pampati; Satya P Sanapati; Mahendra R Sanapati; Alan D Kaye; Joshua A Hirsch
Journal:  Curr Pain Headache Rep       Date:  2020-01-30

2.  The Global Spine Care Initiative: model of care and implementation.

Authors:  Claire D Johnson; Scott Haldeman; Roger Chou; Margareta Nordin; Bart N Green; Pierre Côté; Eric L Hurwitz; Deborah Kopansky-Giles; Emre Acaroğlu; Christine Cedraschi; Arthur Ameis; Kristi Randhawa; Ellen Aartun; Afua Adjei-Kwayisi; Selim Ayhan; Amer Aziz; Teresa Bas; Fiona Blyth; David Borenstein; O'Dane Brady; Peter Brooks; Connie Camilleri; Juan M Castellote; Michael B Clay; Fereydoun Davatchi; Jean Dudler; Robert Dunn; Stefan Eberspaecher; Juan Emmerich; Jean Pierre Farcy; Norman Fisher-Jeffes; Christine Goertz; Michael Grevitt; Erin A Griffith; Najia Hajjaj-Hassouni; Jan Hartvigsen; Maria Hondras; Edward J Kane; Julie Laplante; Nadège Lemeunier; John Mayer; Silvano Mior; Tiro Mmopelwa; Michael Modic; Jean Moss; Rajani Mullerpatan; Elijah Muteti; Lillian Mwaniki; Madeleine Ngandeu-Singwe; Geoff Outerbridge; Shanmuganathan Rajasekaran; Heather Shearer; Matthew Smuck; Erkin Sönmez; Patricia Tavares; Anne Taylor-Vaisey; Carlos Torres; Paola Torres; Alexander van der Horst; Leslie Verville; Emiliano Vialle; Gomatam Vijay Kumar; Adriaan Vlok; William Watters; Chung Chek Wong; Jessica J Wong; Hainan Yu; Selcen Yüksel
Journal:  Eur Spine J       Date:  2018-08-27       Impact factor: 3.134

Review 3.  A call to action: direct access to physical therapy is highly successful in the US military. When will professional bodies, legislatures, and payors provide the same advantages to all US civilian physical therapists?

Authors:  Bryant Clark; Lindsay Clark; Chris Showalter; Travis Stoner
Journal:  J Man Manip Ther       Date:  2022-08

4.  Changes in Pain Catastrophizing and Fear-Avoidance Beliefs as Mediators of Early Physical Therapy on Disability and Pain in Acute Low-Back Pain: A Secondary Analysis of a Clinical Trial.

Authors:  Brittany L Sisco-Taylor; John S Magel; Molly McFadden; Tom Greene; Jincheng Shen; Julie M Fritz
Journal:  Pain Med       Date:  2022-05-30       Impact factor: 3.637

5.  Health seeking behavior as a predictor of healthcare utilization in a population of patients with spinal pain.

Authors:  Derek Clewley; Dan Rhon; Timothy Flynn; Shane Koppenhaver; Chad Cook
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240

6.  Cost-effectiveness of spinal manipulation, exercise, and self-management for spinal pain using an individual participant data meta-analysis approach: a study protocol.

Authors:  Brent Leininger; Gert Bronfort; Roni Evans; James Hodges; Karen Kuntz; John A Nyman
Journal:  Chiropr Man Therap       Date:  2018-11-13

7.  Perception of tertiary care clients toward the availability of physical therapy service at primary health care centers in Saudi Arabia: a cross-sectional survey.

Authors:  Hani Al-Abbad; Sanaa Madi
Journal:  J Phys Ther Sci       Date:  2020-05-01

8.  Effectiveness of bent leg raise technique and neurodynamics in patients with radiating low back pain.

Authors:  Muhammad Adnan; Aatik Arsh; Babar Ali; Shakeel Ahmad
Journal:  Pak J Med Sci       Date:  2022 Jan-Feb       Impact factor: 1.088

9.  Therapeutic lumbar facet joint nerve blocks in the treatment of chronic low back pain: cost utility analysis based on a randomized controlled trial.

Authors:  Laxmaiah Manchikanti; Vidyasagar Pampati; Alan D Kaye; Joshua A Hirsch
Journal:  Korean J Pain       Date:  2018-01-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.